Wilmington-based contract research organization PPD announced yesterday that it has opened an office in Novosibirsk, Russia, to grow its Phase II-IV clinical development services in Eastern Europe.

PPD currently has offices in Moscow, Smolensk and St. Petersburg, Russia, and is one of the largest contract research organizations in Central and Eastern Europe.

“Establishing a presence in Novosibirsk allows us to serve clients more effectively and keep pace with clinical trial growth in this region,” said Roger Newbery, vice president of clinical development for Europe, Middle East and Africa in a press release. “This expansion provides us the ability to reach more than five million people and grow our number of investigator sites to meet growing client demand.”

PPD will provide clinical monitoring services in key therapeutic areas from this location. For more information about PPD services at the Novosibirsk office, call +44 1223 374430.